Trial intelligence / Profile preview

Pentoxifylline added to routine treatment for hospitalized COVID-19 patients

IRCT20170809035597N2Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pentoxifylline, sponsored by Iran University of Medical Sciences. Started Aug 2020; status: completed.

02

Drugs

pentoxifylline

Beyond the preview

Go deeper on IRCT20170809035597N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170809035597N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call